Aging & Elder Health Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging & Elder Health Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Geron Corp.
Study shows utility of small-molecule telomerase activators for HIV/AIDS therapy
April 10th, 2005
Geron Corp. (GERN) announced the presentation of studies showing that its small-molecule telomerase activators, GRN139951 and GRN140665, enhance the functional activity of immune cells from HIV/AIDS donors. The research, presented at the 2005 Palm Springs Symposium on HIV/AIDS, demonstrated the Geron compounds increased the proliferative capacity of cytotoxic T cells and their ability to produce a virus-fighting molecule, gamma Interferon (IFN(gamma)). The new data, presented by Rita Effros, PhD, Elizabeth and Thomas Plott endowed chair in gerontology, professor of pathology and laboratory medicine, and a member of the Universiry of California at Los...
Source: Aging & Elder Health Week (2005-04-10)
|
